Syndros

3 Biotech Stocks With Major Potential Catalysts in July
Yahoo/Motley Fool
Wed, 06/27/18 - 09:45 am
Neurocrine Biosciences
AbbVie
Progenics
INSYS Therapeutics
Elagolix
endometriosis
Azedra
adrenal tumors
Syndros
3 Beaten-Up Biotechs Bouncing Back in 2017 (Hint: One Is a Marijuana Stock)
Motley Fool
Sun, 07/23/17 - 11:44 am
Zogenix
INSYS Therapeutics
Keryx
ZX008
Syndros
Auryxia
Insys cannabinoid drug Syndros given Schedule II status
BioPharma Dive
Sat, 03/25/17 - 12:25 pm
Insys
cannabis
Syndros
HIV-related anorexia
chemotherapy-induced nausea and vomiting
Insys Therapeutics Inc (INSY): FDA Approves Syndros for Cancer, AIDS Patients
Bidness, ETC
Tue, 07/5/16 - 10:22 am
INSYS Therapeutics
FDA
Syndros
AIDS
cancer